Legal Notice

The contents of this website are provided and updated by Neuboron Medtech Ltd. (Neuboron). Neuboron reserves its discretional rights to make any change  to the information and materials as well as the terms, conditions, and statements displayed on or incorporated in this website.


About Intellectuals Properties:

The Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) system, treatment planning software, targeted boron drugs, and the corresponding intellectual properties are independently developed by Neuboron and under protection by over 500 patents globally, including but not limited to the following patents which have been granted:
ZL201410743692.9    ZL201810009982.9    ZL201810009962.1
ZL201410742679.1    ZL201710845531.4    ZL201710845370.9
ZL201710845629.X    ZL201610665056.8    ZL201810262791.3
ZL201510579928.4    ZL201811294634.7    ZL201510629791.9
ZL201520759359.7    ZL201810824287.8    ZL201680017272.X
US10124192B2       US10610704B2        US9974979B2    
US10636534B2       US10323046B2        US10328286B2       US10692283B2
EP3316665B1        EP3032927B1         EP3293161B1
EP3321272B1        EP3254729B1         EP3357537B1
JP6147296B2        JP6334768B2          JP6592135B2     
RU2695255C2       RU2688676C1         RU2682972C1

The ideas of design, website designs, images, arrangements, access method, text, logos, photos, audios, videos, information and content of this website in whatever forms (collectively “Contents”) and the corresponding rights and interest, inter alia, intellectual properties belong to Neuboron.
Without prior written consent by Neuboron, no entity or individual shall make any citation, adaption or duplication of any Contents on this website in whole or in part. Any entity or individual in breach of this notice which incurs damages or losses to Neuboron may be claimed by Neuboron for any legal liabilities.



Demonstration of the Contents or information on this website shall not be construed as an express or implied guarantee with respect to their accuracy, completeness or effectiveness and validity. Neuboron is not liable for any consequence resulting from any unauthorized use or citation of the Contents on this website.

Neuboron provides no medical-related advice through this website. The AB-BNCT system and targeted boron drugs of Neuboron introduced on this website have not be granted marketing authorization by National Medical Products Administration (NMPA) for medical equipment or boron drugs and shall not be used for commercial purposes. Neuboron will not assume any liability for any behavior or loss incurred due to reliance on the Contents on this website.